pcDNA3.1-DTYMK
(Plasmid
#100546)
-
Purposemammalian expression of deoxythymidylate kinase
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 100546 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCDNA3.1+
-
Backbone manufacturerinvitrogen
- Backbone size w/o insert (bp) 5428
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namedeoxythymidylate kinase
-
Alt nameCDC8, PP3731
-
Alt nameTMPK, TYMK, DTYMK
-
SpeciesH. sapiens (human)
-
Insert Size (bp)639
-
Entrez GeneDTYMK (a.k.a. CDC8, PP3731, TMPK, TYMK)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site EcoRV (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer CMV-F
- 3′ sequencing primer BGH-rev (Common Sequencing Primers)
Resource Information
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3.1-DTYMK was a gift from Yuh-Shan Jou (Addgene plasmid # 100546 ; http://n2t.net/addgene:100546 ; RRID:Addgene_100546) -
For your References section:
Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis. Yeh HW, Lee SS, Chang CY, Hu CM, Jou YS. Oncotarget. 2017 Sep 8;8(44):77734-77751. doi: 10.18632/oncotarget.20774. eCollection 2017 Sep 29. 10.18632/oncotarget.20774 PubMed 29100421